The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

Dr. Michelle Tarver, a veteran of the Food and Drug Administration (FDA), has taken charge of the FDA’s device division at a ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Almost every food brand has been affected by product recalls at some point, and Hostess is no different. These are some of ...

Less than a month after the FDA removed Eli Lilly’s tirzepatide from its shortage list, the agency has done the same for Novo Nordisk’s rival GLP-1 semaglutide, potentially signaling the end of a d | ...

CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval from the FDA ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

Stephens initiates coverage on ADC Therapeutics (ADCT), highlighting Zynlonta's potential in second-line DLBCL and a ...

The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...

Learn more about how an anesthetic traditionally used for surgical procedures may help depression and what to expect during ...

Cardiologists from BIDMC, commissioned by the FDA, examined trends in the use and long-term safety of a device for treating ...

few patients with diabetes have been evaluated with the technology since it received FDA approval in 2021, a retrospective ...